Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

BACKGROUND: Adenocarcinoma originating from the digestive system is a major contributor to cancer-related deaths worldwide. Tumor recurrence, advanced local growth and metastasis are key factors that frequently prevent these tumors from curative surgical treatment. Preclinical research has demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Niess, Hanno, von Einem, Jobst C, Thomas, Michael N, Michl, Marlies, Angele, Martin K, Huss, Ralf, Günther, Christine, Nelson, Peter J, Bruns, Christiane J, Heinemann, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393860/
https://www.ncbi.nlm.nih.gov/pubmed/25879229
http://dx.doi.org/10.1186/s12885-015-1241-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393860/
https://www.ncbi.nlm.nih.gov/pubmed/25879229
http://dx.doi.org/10.1186/s12885-015-1241-x

Ejemplares similares